Comment on Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression (vol 43, pg79, 2023)-MedSci.cn

Comment on Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression (vol 43, pg79, 2023)

Wilkowska, A; Cubala, WJ

Wilkowska, A (通讯作者)，Med Univ Gdansk, Fac Med, Dept Psychiat, ul Smoluchowskiego 17, PL-80214 Gdansk, Poland.